{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:04:36Z","timestamp":1787785476641,"version":"build-2784847793"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.leukres.2021.106769","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T12:46:59Z","timestamp":1638190019000},"page":"106769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1)"],"prefix":"10.1016","volume":"112","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banban","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingliang","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2021.106769_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12943-015-0474-2","article-title":"Novel drug targets for personalized precision medicine in relapsed\/refractory diffuse large B-cell lymphoma: a comprehensive review","volume":"14","author":"Camicia","year":"2015","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.leukres.2021.106769_bib0010","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.leukres.2021.106769_bib0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAP.0000000000000117","article-title":"Recent advances in aggressive large B-cell lymphomas: a comprehensive review","volume":"23","author":"Korkolopoulou","year":"2016","journal-title":"Adv. Anat. Pathol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106769_bib0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma","volume":"50","author":"Li","year":"2018","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.leukres.2021.106769_bib0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.critrevonc.2012.12.009","article-title":"Diffuse large B-cell lymphoma","volume":"87","author":"Martelli","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106769_bib0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mayocp.2011.11.007","article-title":"My treatment approach to patients with diffuse large B-cell lymphoma","volume":"87","author":"Armitage","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.leukres.2021.106769_bib0035","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1182\/asheducation-2011.1.498","article-title":"Relapsed\/refractory diffuse large B-cell lymphoma","volume":"2011","author":"Friedberg","year":"2011","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"1","key":"10.1016\/j.leukres.2021.106769_bib0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7150\/thno.21945","article-title":"Exosome theranostics: biology and translational medicine","volume":"8","author":"He","year":"2018","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.leukres.2021.106769_bib0045","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","article-title":"Exosome-Mediated Metastasis: Communication from a Distance","volume":"49","author":"Wortzel","year":"2019","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.leukres.2021.106769_bib0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"10.1016\/j.leukres.2021.106769_bib0055","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ncb1800","article-title":"Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers","volume":"10","author":"Skog","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106769_bib0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.leukres.2021.106769_bib0065","first-page":"5","article-title":"Non-coding RNA networks in cancer, Nature reviews","volume":"18","author":"Anastasiadou","year":"2018","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2021.106769_bib0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/epi-2018-0123","article-title":"Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance","volume":"11","author":"Feng","year":"2019","journal-title":"Epigenomics"},{"key":"10.1016\/j.leukres.2021.106769_bib0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.gene.2017.11.022","article-title":"Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions","volume":"642","author":"Meng","year":"2018","journal-title":"Gene"},{"issue":"7","key":"10.1016\/j.leukres.2021.106769_bib0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41419-019-1705-z","article-title":"miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer","volume":"10","author":"Zhao","year":"2019","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.leukres.2021.106769_bib0085","first-page":"3578","article-title":"Upregulated miR-665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion","volume":"19","author":"Xia","year":"2020","journal-title":"Oncol. Lett."},{"issue":"10","key":"10.1016\/j.leukres.2021.106769_bib0090","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41419-018-0978-y","article-title":"miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB","volume":"9","author":"Hu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.leukres.2021.106769_bib0095","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.2147\/CMAR.S241795","article-title":"miR-665 suppresses the epithelial-mesenchymal transition and progression of gastric Cancer by targeting CRIM1","volume":"12","author":"Wu","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"3","key":"10.1016\/j.leukres.2021.106769_bib0100","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/cas.13921","article-title":"DANCR-mediated microRNA-665 regulates proliferation and metastasis of cervical cancer through the ERK\/SMAD pathway","volume":"110","author":"Cao","year":"2019","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.leukres.2021.106769_bib0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0014-5793(95)01040-L","article-title":"Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains","volume":"373","author":"Tomasetto","year":"1995","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.leukres.2021.106769_bib0110","first-page":"473","article-title":"MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1","volume":"39","author":"Sui","year":"2018","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.leukres.2021.106769_bib0115","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/jgh.13180","article-title":"The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma","volume":"31","author":"Du","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.leukres.2021.106769_bib0120","doi-asserted-by":"crossref","first-page":"13493","DOI":"10.1002\/jcp.28028","article-title":"Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1","volume":"234","author":"Yin","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106769_bib0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s13046-019-1340-7","article-title":"ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p\/LASP1 signaling axis","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.leukres.2021.106769_bib0130","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood-2015-10-671362","article-title":"MYC in DLBCL: partners matter","volume":"126","author":"Campo","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2021.106769_bib0135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41408-019-0271-z","article-title":"High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?","volume":"10","author":"Pophali","year":"2020","journal-title":"Blood Cancer J."},{"issue":"69","key":"10.1016\/j.leukres.2021.106769_bib0140","doi-asserted-by":"crossref","first-page":"33186","DOI":"10.18632\/oncotarget.26046","article-title":"miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth","volume":"9","author":"Prashad","year":"2018","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.leukres.2021.106769_bib0145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/1566524018666180222115103","article-title":"LASP1 in tumor and tumor microenvironment","volume":"17","author":"Hu","year":"2017","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.leukres.2021.106769_bib0150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fonc.2018.00391","article-title":"New frontiers for the cytoskeletal protein LASP1","volume":"8","author":"Butt","year":"2018","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2021.106769_bib0155","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1158\/1078-0432.CCR-20-3139","article-title":"Cobomarsen, an oligonucleotide inhibitor of miR-155, slows DLBCL tumor cell growth in vitro and in vivo","volume":"27","author":"Anastasiadou","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.leukres.2021.106769_bib0160","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s13577-020-00321-1","article-title":"MiR-645 regulates the proliferation and apoptosis of diffuse large B-cell lymphoma by targeting DACH1","volume":"33","author":"Wang","year":"2020","journal-title":"Hum. Cell"},{"key":"10.1016\/j.leukres.2021.106769_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.03.040","article-title":"LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195","volume":"231","author":"Wang","year":"2019","journal-title":"Life Sci."},{"issue":"24","key":"10.1016\/j.leukres.2021.106769_bib0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.leukres.2021.106769_bib0175","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1002\/jcp.29349","article-title":"miR-665 promotes the progression of gastric adenocarcinoma via elevating FAK activation through targeting SOCS3 and is negatively regulated by lncRNA MEG3","volume":"235","author":"Tang","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106769_bib0180","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00432-014-1823-z","article-title":"Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK\/Src pathway","volume":"141","author":"Li","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106769_bib0185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.leukres.2021.106769_bib0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.seminhematol.2015.01.009","article-title":"MYC alterations in diffuse large B-cell lymphomas","volume":"52","author":"Karube","year":"2015","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.leukres.2021.106769_bib0195","doi-asserted-by":"crossref","first-page":"25631","DOI":"10.1038\/srep25631","article-title":"Loss of the 14-3-3\u03c3 is essential for LASP1-mediated colorectal cancer progression via activating PI3K\/AKT signaling pathway","volume":"6","author":"Shao","year":"2016","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.leukres.2021.106769_bib0200","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.1602907","article-title":"Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control","volume":"21","author":"Zhao","year":"2007","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.leukres.2021.106769_bib0205","first-page":"6490","article-title":"LASP1 induces colorectal cancer proliferation and invasiveness through Hippo signaling and Nanog mediated EMT","volume":"12","author":"Chen","year":"2020","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.leukres.2021.106769_bib0210","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3892\/or.2016.5223","article-title":"Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: key role of the NF-\u03baB pathway","volume":"37","author":"Sun","year":"2017","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.leukres.2021.106769_bib0215","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrclinonc.2013.197","article-title":"Diffuse large B-cell lymphoma-treatment approaches in the molecular era","volume":"11","author":"Roschewski","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"39","key":"10.1016\/j.leukres.2021.106769_bib0220","doi-asserted-by":"crossref","first-page":"64244","DOI":"10.18632\/oncotarget.11720","article-title":"Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1)","volume":"7","author":"Endres","year":"2016","journal-title":"Oncotarget"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621017707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621017707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:02:28Z","timestamp":1758934948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621017707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":44,"alternative-id":["S0145212621017707"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106769","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1)","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106769"}}